Literature DB >> 21888141

Social implications of leprosy in the Netherlands--stigma among ex-leprosy patients in a non-endemic setting.

Roos De Groot1, Wim H Van Brakel, Henry J C De Vries.   

Abstract

BACKGROUND: In the Netherlands, leprosy is a rare and non-endemic disease, still occurring as an 'import disease'. Moreover a considerable group of people affected by leprosy, originating mainly from the former Dutch colonies, suffer from neuropathic complications. This study investigates the social implications of leprosy for those affected in the Netherlands.
METHODS: Thirty-one people affected were interviewed as well as six medical leprosy experts. The social implications were measured by means of semi-structured interviews and the Participation Scale.
RESULTS: Self-stigma, shame and secrecy were often reported. Discrimination and stigmatisation of ex-leprosy patients by people around them seems a less frequent problem. Yet, people affected by leprosy seem to be a forgotten group with a high social burden due to low self-esteem and reduced social participation. Medical experts do not seem to be aware of the severity of leprosy-related forms of stigma in their patients. Ex-leprosy patients lack sound disease-related information and support groups. Due to the low incidence and as a consequence, the lack of awareness among doctors, leprosy patients in the Netherlands are faced with substantial diagnostic delay (mean delay 1-8 years).
CONCLUSIONS: Leprosy and its stigma affect the social lives of patients, even in a non-endemic area such as the Netherlands. Almost all respondents were affected by self-stigma. There is a need for 1) more information and support groups for patients, and 2) increased awareness among professionals.

Entities:  

Mesh:

Year:  2011        PMID: 21888141

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  6 in total

Review 1.  Leprosy in the 21st century.

Authors:  Cassandra White; Carlos Franco-Paredes
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Factors affecting perceived stigma in leprosy affected persons in western Nepal.

Authors:  Bipin Adhikari; Nils Kaehler; Robert S Chapman; Shristi Raut; Paul Roche
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

3.  Psychometric assessment of the EMIC Stigma Scale for Brazilians affected by leprosy.

Authors:  Fabiane Frota da Rocha Morgado; Erika Maria Kopp Xavier da Silveira; Lilian Pinheiro Rodrigues do Nascimento; Anna Maria Sales; José Augusto da Costa Nery; Euzenir Nunes Sarno; Ximena Illarramendi
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

4.  Social participation of diabetes and ex-leprosy patients in the Netherlands and patient preference for combined self-care groups.

Authors:  Henry J C de Vries; Roos de Groot; Wim H van Brakel
Journal:  Front Med (Lausanne)       Date:  2014-08-18

5.  Inequality of leprosy disability in iran, clinical or socio-economic inequality: an extended concentration index decomposition approach.

Authors:  Rasool Entezarmahdi; Reza Majdzadeh; Abbas Rahimi Foroushani; Mahshid Nasehi; Abolfath Lameei; Kourosh Holakouie Naieni
Journal:  Int J Prev Med       Date:  2014-04

6.  Leprosy in England and Wales 1953-2012: surveillance and challenges in low incidence countries.

Authors:  Nicholas Fulton; Laura F Anderson; John M Watson; Ibrahim Abubakar
Journal:  BMJ Open       Date:  2016-05-03       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.